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ABSTRACT
Hepatocellular carcinoma is the most common primary liver malignancy and is an interna-
tional public health concern, constituting one of the most deadly cancers worldwide. Infec-
tion with hepatitis B virus and hepatitis C virus is a major risk factor for HCC in developed 
countries. Emerging evidence indicates that there are other important lifestyle factors that 
contribute to the international burden of HCC, such as alcohol consumption, diabetes, obes-
ity, and the intake of aflotoxin-contaminated food. Obesity and diabetes are also likely to be 
risk factors for HCC, the most frequent subtype of liver cancer. The chief pathway by which 
obesity increases risk involves the association between obesity and nonalcoholic fatty liver 
disease (NAFLD). Coffee consumption has been studied extensively and appears to have a fa-
vorable effect on the prevention of liver diseases, including HCC. One hypothesis suggests 
that coffee intake lowers serum levels of gamma-glutamyltransferase (GGT), which is asso-
ciated with a lower incidence of HCC. It is estimated that more than 80% of HCC cases are 
attributable to four principal causes that are avoidable. It is difficult to make dietary recom-
mendations, because it is unknown whether consuming higher amounts of specific antioxi-
dants will decrease the risk of developing hepatocellular carcinoma. A diet rich that is in 
polyunsaturated fatty acids and, possibly, B-carotene could reduce the risk of HCC, and high 
dietary GL is associated with an increased risk independently of cirrhosis or diabetes. 
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Editorial        
  c 2011 Kowsar M.P.Co. All rights reserved.
Hepatocellular  carcinoma  (HCC)  is  the  most  common 
primary liver malignancy and represents an international 
public health concern, constituting one of the most deadly 
cancers worldwide (1). Infection with hepatitis B virus (HBV) 
and hepatitis C virus (HCV) is a major risk factor for HCC in 
developed countries (2). Over the past several decades, HCC 
incidence and mortality have increased in the United States, 
Japan, and several European countries (1-5). Similar trends 
in obesity have implicated an association between the risk 
of HCC and excessive weight. A recent meta-analysis, which 
summarized  the  evidence  from  cohort  studies,  noted  in-
creased HCC risks of 17% for overweight people and 90% for 
obese persons, compared with those with normal weight (6, 
7). Infection with hepatitis C (HCV) and/or hepatitis B (HBV) 
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virus and elevated alcohol consumption are leading risk fac-
tors for HCC, accounting for ~90% of cases (BIBMM). Other 
factors might also contribute, including medical conditions, 
smoking habits, and diet (8).
Emerging  evidence  indicates  that  the  etiology  of  many 
cases of HCC is multifactorial, comprising infectious origins, 
comorbid conditions, and environmental exposure. Accord-
ingly, many cases are attributed to the growing prevalence 
of chronic infections with hepatitis B and hepatitis C viruses 
(1-9).  However,  there  are  other  important  lifestyle  factors 
that contribute to the international burden of HCC, such as 
alcohol consumption, diabetes, obesity, and intake of aflo-
toxin-contaminated  food  (8,  10-12).  Alcohol  consumption 
increases the risk of HCC primarily through the develop-
ment of cirrhosis. This risk appears to be proportional to the 
amount of alcohol that is consumed (13). In addition, an as-
sociation between genetic polymorphisms of enzymes (e.g., 
aldehyde dehydrogenase 2) that mediate the metabolism of 
ethanol and an increased risk of HCC in heavy alcohol drink-Hepat Mon. 2011;11(3):159-162
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ers has been also proposed as a mechanism through which 
HCC develops (14).
Obesity is another risk factor for several chronic diseases, 
including hypertension, insulin resistance (IR), type 2 diabe-
tes, dyslipidemia, and chronic heart disease (15). Collective-
ly, abdominal obesity, IR, dyslipidemia, and elevated blood 
pressure are known as the metabolic syndrome, reflecting 
overnutrition, a sedentary lifestyle, and resultant excess adi-
posity, which is associated with a chronic proinflammatory 
state (15, 16). Notably, obesity and diabetes are also likely to 
be risk factors for HCC, the most frequent subtype of liver 
cancer. The chief pathway by which obesity increases risk 
involves the association between obesity and nonalcoholic 
fatty liver disease (NAFLD) (17). NAFLD is the most common 
cause of chronic liver disease among adults in western coun-
tries (18). NAFLD comprises a spectrum of conditions, rang-
ing from fat alone to fat plus inflammation, fat plus balloon-
ing degeneration, and nonalcoholic steatohepatitis (NASH), 
which is a well-recognized cause of cirrhosis and has been in-
creasingly associated with the development of carcinoma.
As the hepatic entity of metabolic syndrome, NAFLD/NASH 
is a risk factor for HCC, even in the absence of cirrhosis (19). 
A recent study has shown that NAFLD is a principal risk fac-
tor in the development of HCC, irrespective of age (20). Accu-
mulating evidence also suggests that visceral adipose tissue 
secretes vascular endothelial growth factor (VEGF) and other 
adipokines, implicating the dysregulation of angiogenesis 
as a connection between obesity and worse clinical outcome 
(21). In animal models, leptin promotes angiogenesis and 
thus can facilitate the progression of NASH to HCC (22). Lep-
tin also activates many signal transduction pathways, such 
as JNK, protein kinase B, AKT, and the extracellular signal-
regulated kinase pathway in HCC cells, all of which promote 
the progression of cancer (23).
In addition to increasing the prevalence of chronic liver 
disease, diabetes is an independent risk factor for the de-
velopment of HCC. In a recent systematic review of 13 case 
control studies, 11 reports supported an association between 
diabetes and the development of HCC (24). Of the 13 case 
control studies, subjects with diabetes had a 2-fold higher 
risk of HCC (24). The presence of diabetes remained an inde-
pendent risk factor of HCC after adjusting for alcohol use or 
viral hepatitis (10, 11). Many case reports and case reviews of 
HCC in NASH have supported the association of diabetes and 
obesity with the risk of HCC and have implicated age and 
advanced fibrosis as significant risks. Insulin resistance and 
the resulting inflammatory cascade, which are associated 
with the development of NASH, appear to mediate carcino-
gens go HCC. The incidence of NASH is expected to increase 
with the growing epidemic of diabetes and obesity (25).
Coffee consumption has also been extensively studied and 
appears to have a favorable effect on the prevention of liver 
diseases, including HCC (26). There are several hypotheses 
that explain why coffee attenuates the risk of HCC. One hy-
pothesis suggests that coffee intake lowers serum levels of 
gamma-glutamyltransferase (GGT), which is associated with 
a lower incidence of HCC (10). Coffee consumption has also 
been linked to a lower incidence of cirrhosis, which is a ma-
jor risk factor for the development of HCC (27, 28). Several 
studies have examined whether alterations in diet affect the 
risk of HCC. For example, a trial from Italy studied a broad 
range of dietary habits in 185 patients with HCC and 142 pa-
tients without cancer. Those with HCC were more likely to 
consume more calories, were 5 times more likely to be for-
mer drinkers, and were 30 times more likely to be infected 
with HCV or hepatitis B virus (29). The consumption of iron 
and thiamine was associated with a significant 3-fold and 
2-fold increase in the risk of HCC, respectively. In contrast, 
α-carotene  and  linoleic  acid  consumption  was  associated 
with a reduced risk of HCC (29, 30).
In a similar study, in the highest quartile of consumers 
of yogurt and milk, the intake of white meat and eggs cor-
related with a significantly lower likelihood of the devel-
opment of HCC. This effect was observed in patients with 
and without viral hepatitis (12). Other studies have recently 
shown that red meat and saturated fat are associated with 
increased chronic liver disease (CLD) and hepatocellular car-
cinoma (31). Several mechanisms, involving fat, iron, hetero-
cyclic amines, and N-nitroso compounds, link meat intake 
with  chronic  liver  disease  and  hepatocellular  carcinoma. 
Notably, amino acid-defined diets that are deficient in meth-
yl groups effect a high incidence of HCC. A methyl-deficient 
diet can induce liver injuries that resemble human nonalco-
holic steatohepatitis, one of the principal risk factors for the 
development of HCC. Such a diet disrupts DNA methylation 
by causing a profound loss of global cytosine methylation, 
predominantly at heavily methylated repetitive sequences. 
As a consequence, many genes are differentially expressed 
and correlate inversely with the extent of CpG island methy-
lation  (32).  Furthermore,  these  genes  are  associated  with 
altered lipid and glucose metabolism, DNA damage and re-
pair, apoptosis, the development of fibrosis, and liver tissue 
remodeling.
Another important risk factor for the development of HCC 
is the contamination of foodstuffs with aflotoxin B1 (AFB1). 
AFB1 is a mycotoxin that is produced by the fungus Asper-
gillus, which grows readily on food when it is stored under 
warm, damp conditions (33, 34). When ingested, it is me-
tabolized into the active AFB1-exo-8, 9-epoxide, which binds 
to DNA and causes damage, such as mutations in the p53 
tumor suppressor gene. This mutation has been reported in 
50% of HCC tumors in southern Africa, where aflotoxin B1 is a 
known risk factor of HCC (33, 35). A prospective case control 
study from China of 18244 middle-aged men demonstrated 
that individuals who expressed urinary aflotoxin biomark-
ers had a significantly greater risk of HCC after adjustments 
for HBV surface antigen seropositivity and cigarette smok-
ing. Recent research suggests that the intake of several di-
etary antioxidants (e.g., coenzyme Q(12), vitamin C and E, 
selenium) and phytochemicals (e.g., ellagic acid, curcumin, 
lycopene, epigallocatechin gallate, and resveratrol) that are 
present in fruit, vegetables, herbs and medicinal plants can 
prevent cardiovascular abnormalities, neurodegeneration, 
and  hepatocarcinogenesis  (36,  37).  These  phytochemicals 
not only have antioxidant properties but also activate cel-
lular  stress  response  pathways  through  the  induction  of 
kinases and transcription factors, leading to the expression 
of antioxidants and phase II enzymes. Activation of the Nrf2 
transcription  factor-antioxidant  response  element  (ARE) 
pathway  by  these  phytochemicals  effects  cytoprotection 
and chemoprevention (38).
However,  the  hermetic  effects  of  these  phytochemicals 
must be considered, because at low doses they have stimula-
tory effects but are toxic at higher doses (39). Various studies 
from Japan and Europe have found that those who consume 
large amounts of green vegetables have a significantly lower Hepat Mon. 2011;11(3):159-162
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risk of developing HCC (39, 40). One study has demonstrated 
that the daily consumption of green vegetables, compared 
with several times per week, has a protective effect against 
the development of HCC. In contrast, a Greek study failed to 
note an association between vegetable intake and a reduc-
tion in the risk of developing HCC (41). In conclusion, more 
than 80% of HCC cases are estimated to be attributed to four 
principal causes that are avoidable. Hepatitis-negative HCC 
in men is effected primarily by heavy alcohol consumption. 
Diet is involved in the risk of HCC; specifically, the beneficial 
effect  of  certain  dietary  products,  such  as  fruits  and  veg-
etables, is independent of other major risk factors (e.g., HBV 
and HCV infections).
Due to conflicting results, it is difficult to make dietary rec-
ommendations, because it is unknown whether consuming 
higher amounts of specific antioxidants will decrease the 
risk of developing hepatocellular carcinoma. A diet that is 
rich in polyunsaturated fatty acids and, possibly, B-carotene 
can reduce the risk of HCC, and high dietary GL is associated 
with increased risk, independently of cirrhosis or diabetes. 
Coffee has favorable effects, as shown in many studies, espe-
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